Systematic review / meta-analysis / 2012
Omega-3 supplementation was not linked to lower risk of major cardiovascular events.
A meta-analysis examined 20 randomized trials including 68,680 participants. Omega-3 supplementation was not statistically significantly associated with all-cause mortality (RR 0.96, 95% CI 0.91 to 1.02), cardiac death (RR 0.91, 95% CI 0.85 to 0.98; significance threshold P = .0063), sudden death, myocardial infarction, or stroke. Neither relative nor absolute risk reductions met the threshold for significance across major cardiovascular outcomes.
- Study type
- Meta-analysis of randomized controlled trials
- Who was studied
- 68,680 patients across 20 randomized clinical trials
- What was measured
- All-cause mortality and major cardiovascular events
THE PAPER
Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.
Rizos EC, Ntzani EE, Bika E, Kostapanos MS, Elisaf MS. JAMA, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.